Konsume
Interval Day Week Month
Newswire Search Past 90 Days 556 stories 159 Publishers
Trending Today
Sort By: Snapshot
Buzz
Media Coverage
World View

Related Topics
Topic # Mentions Topic Reach
the87-
data27-
phase18-
future18-
startup16-
pharma14-
beagles14-
bank12-
ipo11-
company11-
tech10-
world9-
innovation9-
new haven8-
medical8-
giant8-
next7-
study7-
business7-
weekly buzz7-
launches7-
center6-
news6-
sciences6-
grant6-
heard6-
cut6-
therapeutics6-
develop5-
watch5-
running5-
edge5-
saudi5-
orleans5-
ramaswamy5-
firm5-
boost4-
strong4-
summit4-
pipeline4-
life sciences4-
saudi arabia4-
branford4-
treasury4-
parkinson4-
blood4-
san4-
weight4-
israeli4-
stanford3-
Prominent Journalists
Byline Articles Written Avg Reach
RTTNews Staff Writer 66 -
Meghana Keshavan 21 -
Prabha Kurup 17 -
Adam Feuerstein 10 -
Gayathry Prakash 10 -
Elaine Chen 10 -
Frank Vinluan 10 -
Greg Bordonaro 9 -
by PR Newswire 8 -
TajSabreen Ahamed 7 -
Adithi Ramakrishnan | The Associated Press 5 -
PR Newswire 5 -
Jorge Mercado 5 -
The Hindu Bureau 5 -
David Krechevsky 4 -
Allison DeAngelis 4 -
Tribune News Service 4 -
Jessica Hamzelou 4 -
Sharmila Bhadoria 4 -
Noelle Harff 4 -


Patients Deaths and Data Shortfall Spell the End for Cell Therapy Biotech Artiva

Frank Vinluan — medcitynews.com


RFK Jr. goes for broke in Iowa

John Wilkerson — statnews.com


Phase 2 Vs Phase 3 Clinical Trials: Why The Difference Matters Enormously For Investors?

Gayathry Prakash — rttnews.com


Q2 Results Highlights 27th Oct: Bajaj Auto Q2 PAT up 35%, Maruti Suzuki & Cipla profit down, ACC, Mazagon Dock PAT tumbles, Honeywell Automation PAT up, L&T, Vedanta Iron, Waaree Energies, SAIL, SBI Life, Tata Capital, Star Health, ABDL to announce Q2 results

KS Badri Narayanan — thehindubusinessline.com


California biotech experiments with treatment for Parkinson’s. Now it’s going public.

Noelle Harff — mercurynews.com


As politicians argue about China, US patients find cutting-edge treatment there

Tribune News Service — ukiahdailyjournal.com


PYC Therapeutics Shares Surge 9.4% as RNA Drug Developer Rebounds After Pullback Following Kidney Disease Data

Tony Jackson — ibtimes.com.au


Lycia Shares Fall Nearly 10% After Hours Following $365.1 Mln IPO Closing

RTTNews Staff Writer — rttnews.com


Why Biotech Needs Partners—and an Informed Public · TechNode

More by Lucia — technode.com


San Diego biotech experiments with treatment for Parkinson’s. Now it’s going public.

Noelle Harff — sandiegouniontribune.com

Execution: 2.66 Seconds. 33.8 mb used.